WIC
MBII

Whitegate Investment Counselors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Whitegate Investment Counselors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,000
Closed -$23K – 202
2019
Q1 		$23K Hold
15,000
– – ﹤0.01% 196
2018
Q4 		$22K Hold
15,000
– – 0.01% 191
2018
Q3 		$27K Hold
15,000
– – 0.01% 171
2018
Q2 		$28K Hold
15,000
– – 0.01% 195
2018
Q1 		$30K Buy
+15,000
New +$20.1K 0.01% 191

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Whitegate Investment Counselors's MBII Position: Q2 2019 in Review

Whitegate Investment Counselors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2019, closing a stake of 15,000 shares — an estimated $23K sold.

Whitegate Investment Counselors first reported a position in MBII in Q1 2018 and held it in 5 quarters. The position peaked at $30K in Q1 2018. 49 funds tracked by Wall St. Rank hold MBII as of Q2 2019.

  • Whitegate Investment Counselors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2019 after selling out during the quarter.
  • Whitegate Investment Counselors sold 15,000 Marrone Bio Innovations, Inc. shares in Q2 2019, an estimated $23K.
  • Whitegate Investment Counselors first reported a position in Marrone Bio Innovations, Inc. in Q1 2018 and held it in 5 quarters.
  • Whitegate Investment Counselors's Marrone Bio Innovations, Inc. position peaked at $30K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2019.

Based on Whitegate Investment Counselors's 13F filing for Q2 2019, filed 26 Jul 2019.